NF-κB promotes inflammatory cytokines (e.g., IL-6, IL-1β) production to exacerbate renal inflammation associated with acute kidney injury (AKI) and diabetic nephropathy, which is largely suppressed by JSH-23 (NF-κB inhibitor) [37,38,39]. The gene discussed is NFKB1; the disease is diabetic kidney disease.